Clinical Trial Update: A Study to Evaluate the Effects of Vildagliptin on the Insulin Response to Glucose in Subjects With Pre-diabetes [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the effects of vildagliptin on insulin response to glucose in individuals with prediabetes has completed. No efficacy results are provi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prediabetes

Drugs mentioned

• Vildagliptin (vildagliptin)

Snippet

Sponsor: Novartis | Conditions: Pre-diabetes | Phase 3 | Status: COMPLETED